Ind-Swift Laboratories Ltd (INDSWFTLAB) — Announcement | 27 August 2026
Ind-Swift Laboratories clarified that a recent spike in share volume and price was market-driven with no company-specific cause, reaffirming compliance with SEBI regulations and stating no awareness of reasons behind the movement.
About Ind-Swift Laboratories Ltd (INDSWFTLAB)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when INDSWFTLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track INDSWFTLAB — Free💡 Ask AI about this filing
📊 More INDSWFTLAB filings
- Announcement — 28 September 2026Ind-Swift Laboratories informed physical security holders that SEBI mandates updating PAN, KYC, and ...
- Announcement — 28 September 2026Ind-Swift Laboratories Ltd announced the closure of its trading window effective 1 October 2026, pro...
- 🔴 Announcement — 23 September 2026Ind-Swift Laboratories announced its schedule for an upcoming analyst and institutional investor mee...
- regulation 29 — 21 September 2026Ind-Swift Laboratories disclosed that Essix Biosciences acquired 7 million fully convertible warrant...
- 🔴 Corporate Action — 17 September 2026Ind-Swift Laboratories announced the allotment of 7 million fully convertible warrants to Essix Bios...
🔥 Also filed on 27 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when INDSWFTLAB files new disclosures
Track INDSWFTLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track INDSWFTLAB — FreeFree account · 2 AI queries/day